More recently, PL has been reported to effectively ameliorate liver fibrosis via downregulation of epidermal growth factor receptor (EGFR), STAT3, alpha-smooth muscle actin (α-SMA), ROS-mediated NF-кB signaling pathway, and inhibition of inflammation and collagen production [17–20]. This evidence concerns the gene ACTA1 and Hepatic fibrosis.